Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EFFECT OF PARICALCITOL (ZEMPLAR) ON ENDOTHELIAL FUNCTION AND INFLAMMATION IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE

NCT01792206 is registered in ClinicalTrials.gov with Scott and White Hospital & Clinic as lead sponsor.

NCT NCT01792206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01792206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EFFECT OF PARICALCITOL (ZEMPLAR) ON ENDOTHELIAL FUNCTION AND INFLAMMATION IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
Lead sponsor
Scott and White Hospital & Clinic
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2009
Completion date
February 28, 2013
Enrollment
60 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, type 2 diabetes